[Efficacy of trazodone in the treatment of insomnia]. 2010

Piotr Gałecki, and Antoni Florkowski, and Monika Talarowska
Uniwersytet Medyczny w Łodzi, Klinika Psychiatrii Dorosłych. galeckipiotr@wp.pl

Sleep disorders are among the most common in the general population. Insomnia is a serious clinical and social problems. The prevalence of insomnia in developed countries is estimated at 10-35% (40%). The effective treatment of insomnia, it is essential to proper diagnosis and treatment of the primary causes. When choosing an antidepressant for a patient with sleep disorders should be taken into account the effectiveness of antidepressant, sedative activity profile, good tolerability and possible administration evening dose. Trazodone is an sedative antidepressant, acting quickly, efficiently, safely, with a small number of adverse reactions and proven effective in the treatment of insomnia.

UI MeSH Term Description Entries
D007319 Sleep Initiation and Maintenance Disorders Disorders characterized by impairment of the ability to initiate or maintain sleep. This may occur as a primary disorder or in association with another medical or psychiatric condition. Disorders of Initiating and Maintaining Sleep,Insomnia,Sleeplessness,Chronic Insomnia,DIMS (Disorders of Initiating and Maintaining Sleep),Early Awakening,Insomnia Disorder,Nonorganic Insomnia,Primary Insomnia,Psychophysiological Insomnia,Rebound Insomnia,Secondary Insomnia,Sleep Initiation Dysfunction,Transient Insomnia,Awakening, Early,Dysfunction, Sleep Initiation,Dysfunctions, Sleep Initiation,Insomnia Disorders,Insomnia, Chronic,Insomnia, Nonorganic,Insomnia, Primary,Insomnia, Psychophysiological,Insomnia, Rebound,Insomnia, Secondary,Insomnia, Transient,Insomnias,Sleep Initiation Dysfunctions
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014196 Trazodone A serotonin uptake inhibitor that is used as an antidepressive agent. It has been shown to be effective in patients with major depressive disorders and other subsets of depressive disorders. It is generally more useful in depressive disorders associated with insomnia and anxiety. This drug does not aggravate psychotic symptoms in patients with schizophrenia or schizoaffective disorders. (From AMA Drug Evaluations Annual, 1994, p309) AF-1161,Apo-Trazodone,Deprax,Desyrel,Gen-Trazodone,Molipaxin,Novo-Trazodone,Nu-Trazodone,PMS-Trazodone,Ratio-Trazodone,Thombran,Tradozone,Trazodon Hexal,Trazodon-Neuraxpharm,Trazodone Hydrochloride,Trazon,Trittico,AF 1161,AF1161,Apo Trazodone,Gen Trazodone,Novo Trazodone,Nu Trazodone,PMS Trazodone,Ratio Trazodone,RatioTrazodone,Trazodon Neuraxpharm,TrazodonNeuraxpharm
D018687 Antidepressive Agents, Second-Generation A structurally and mechanistically diverse group of drugs that are not tricyclics or monoamine oxidase inhibitors. The most clinically important appear to act selectively on serotonergic systems, especially by inhibiting serotonin reuptake. Antidepressants, Atypical,Atypical Antidepressants,Second-Generation Antidepressive Agents,Antidepressive Drugs, Second-Generation,Agents, Second-Generation Antidepressive,Antidepressive Agents, Second Generation,Antidepressive Drugs, Second Generation,Drugs, Second-Generation Antidepressive,Second Generation Antidepressive Agents,Second-Generation Antidepressive Drugs

Related Publications

Piotr Gałecki, and Antoni Florkowski, and Monika Talarowska
May 2015, Hospital pharmacy,
Piotr Gałecki, and Antoni Florkowski, and Monika Talarowska
April 2005, The Journal of clinical psychiatry,
Piotr Gałecki, and Antoni Florkowski, and Monika Talarowska
August 2021, Psychiatria polska,
Piotr Gałecki, and Antoni Florkowski, and Monika Talarowska
September 2005, Pharmacopsychiatry,
Piotr Gałecki, and Antoni Florkowski, and Monika Talarowska
July 1994, The American journal of psychiatry,
Piotr Gałecki, and Antoni Florkowski, and Monika Talarowska
January 2020, Rivista di psichiatria,
Piotr Gałecki, and Antoni Florkowski, and Monika Talarowska
January 2017, Innovations in clinical neuroscience,
Piotr Gałecki, and Antoni Florkowski, and Monika Talarowska
April 2023, Hospital pharmacy,
Piotr Gałecki, and Antoni Florkowski, and Monika Talarowska
January 2004, The Journal of clinical psychiatry,
Piotr Gałecki, and Antoni Florkowski, and Monika Talarowska
May 2018, Sleep medicine,
Copied contents to your clipboard!